Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

94.70USD
28 Aug 2014
Price Change (% chg)

$-0.04 (-0.04%)
Prev Close
$94.74
Open
$94.00
Day's High
$95.25
Day's Low
$93.75
Volume
2,732,983
Avg. Vol
4,539,792
52-wk High
$96.15
52-wk Low
$66.85

Search Stocks
KARSEN PERRY A Options Exercised: 5,185
Trade Date: Thursday, 31 Oct 2013 Price: 0.00
Title: Chief Operating Officer Shares Held: 18,923
Type Traded: Direct Net Change in Shares This Filing: 4,815

Institutional Holders

% Shares Owned: 82.74%
# of Holders: 1,309
Total Shares Held: 661,536,552
3 Mo. Net Change: 5,074,129
# New Positions: 117
# Closed Positions: 84
# Increased Positions: 524
# Reduced Positions: 604
# Net Buyers: -80

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

56 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks